Login to Your Account

Financings Roundup

Friday, June 14, 2013
Esperion Therapeutics Inc., of Plymouth, Mich., filed terms for its initial public offering, planning to raise $63 million by offering 4.5 million shares at a price range of $13 to $15.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription